External validation of a prognostic model to predict survival of patients with sentinel node-negative melanoma — Norbertus A. Ipenburg (2019) | RDL Network
External validation of a prognostic model to predict survival of patients with sentinel node-negative melanoma
Article 2019 en
Authors
NI
Norbertus A. Ipenburg
ON
Omgo E. Nieweg
TA
Tasnia Ahmed
Abstract
1 min read
This study validated the EORTC prognostic model for recurrence-free and melanoma-specific survival of patients with negative sentinel nodes. The addition of other prognostic factors only improved the model marginally. The validated EORTC model could be used for personalizing follow-up and selecting high-risk patients for trials of adjuvant systemic therapy.
M.A. El Sharouni, Tasnia Ahmed, Arjen J. Witkamp, V. Sigurdsson, Carla H. van Gils, Omgo E. Nieweg, Richard A Scolyer, John F. Thompson, P. J. van Diest, Serigne Lo
Serigne Lo, Mary‐Ann El Sharouni, Karijn P.M. Suijkerbuijk, Tasnia Ahmed, Witkamp Arjen, Anne Ε. Cust, V. Sigurdsson, P. J. van Diest, Richard A Scolyer, Carla H. van Gils, John F. Thompson
Kimberley L. Kaufman, Swetlana Mactier, Nicola J. Armstrong, Duthika M. Mallawaaratchy, Scott N. Byrne, Lauren E. Haydu, Valerie Jakrot, John F. Thompson, Graham J. Mann, Richard A Scolyer, Richard I. Christopherson
Discussion(0)
No comments yet. Be the first to comment.